Skip to main content
Industry News
Study shows benefits of using AI in prostate cancer

Swedish researchers analyzed needle core biopsy slides from men with prostate cancer and found that using an artificial intelligence system can help detect and grade prostate cancer, as well as distinguish benign biopsy cores from malignant ones. The findings, published in The Lancet Oncology, also showed that the association between the AI-predicted cancer length and the one assigned by reporting pathologists was 0.96 for the independent data set and 0.87 for the external validation data set.

Full Story: